E-LIB Suche - Ergebnisse für: Kowanetz, Marcin

1

Case report: A persistently expanded T cell response in an ..:

Coffey, David G. ; Xu, Yuexin ; Towlerton, Andrea M. H....
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

2

C-reactive protein reduction post treatment is associated w..:

Patil, Namrata S. ; Zou, Wei ; Mocci, Simonetta...
PLOS ONE. 16 (2021) 2 - p. e0246486 , 2021

Link: https://doi.org/10.1371/..

3

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 ..:

Banchereau, Romain ; Chitre, Avantika S. ; Scherl, Alexis...
Journal for ImmunoTherapy of Cancer. 9 (2021) 4 - p. e002231 , 2021

Link: https://doi.org/10.1136/..

4

Clinical Activity and Safety of Atezolizumab in a Phase 1 S..:

Chiang, Anne C. ; Sequist, Lecia Van Dam ; Gilbert, Jill...
Clinical Lung Cancer. 21 (2020) 5 - p. 455-463.e4 , 2020

Link: https://doi.org/10.1016/..

5

Absence of PD-L1 expression on tumor cells in the context o..:

Theelen, Willemijn S. M. E. ; Kuilman, Thomas ; Schulze, Katja...
PLOS ONE. 14 (2019) 5 - p. e0216864 , 2019

Link: https://doi.org/10.1371/..

6

Immune profiles in primary squamous cell carcinoma of the h..:

Saloura, Vassiliki ; Izumchenko, Evgeny ; Zuo, Zhixiang...
Oral Oncology. 96 (2019) - p. 77-88 , 2019

Link: https://doi.org/10.1016/..

7

Late-differentiated effector neoantigen-specific CD8+ T cel..:

Fehlings, Michael ; Jhunjhunwala, Suchit ; Kowanetz, Marcin...
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

8

Development of a PD-L1 Complementary Diagnostic Immunohisto..:

Vennapusa, Bharathi ; Baker, Brian ; Kowanetz, Marcin...
Applied Immunohistochemistry & Molecular Morphology. 27 (2019) 2 - p. 92-100 , 2019

Link: https://doi.org/10.1097/..

9

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II..:

Spigel, David R. ; Chaft, Jamie E. ; Gettinger, Scott...
Journal of Thoracic Oncology. 13 (2018) 11 - p. 1733-1742 , 2018

Link: https://doi.org/10.1016/..

10

Predictive Biomarkers and Targeted Therapies in Immuno-onco..:

, In: Predictive Biomarkers in Oncology,

Koeppen, Hartmut ; McCleland, Mark L. ; Kowanetz, Marcin - p. 335-344 , 2018

Link: https://doi.org/10.1007/..

11

Differential regulation of PD-L1 expression by immune and t..:

Kowanetz, Marcin ; Zou, Wei ; Gettinger, Scott N....
Proceedings of the National Academy of Sciences. 115 (2018) 43 - p. , 2018

Link: https://doi.org/10.1073/..

12

Differential regulation of PD-L1 expression by immune and t..:

Kowanetz, Marcin ; Zou, Wei ; Gettinger, Scott N....
Proceedings of the National Academy of Sciences of the United States of America. 115 (2018) 43 - p. E10119-E10126 , 2018

Link: https://www.jstor.org/st..

13

Immune Signaling in Carcinogenesis:

, In: Predictive Biomarkers in Oncology,

Yadav, Mahesh ; Kowanetz, Marcin ; Koeppen, Hartmut - p. 327-334 , 2018

Link: https://doi.org/10.1007/..

14

Safety and clinical activity of atezolizumab monotherapy in..:

Horn, Leora ; Gettinger, Scott N. ; Gordon, Michael S....
European Journal of Cancer. 101 (2018) - p. 201-209 , 2018

Link: https://doi.org/10.1016/..

15

PL04a.02: OAK, a Randomized Ph III Study of Atezolizumab vs..:

Gadgeel, Shirish ; Ciardiello, Fortunato ; Rittmeyer, Achim...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S9-S10 , 2017

Link: https://doi.org/10.1016/..